Hearing Aid Pediatric denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for hearing aid pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied Your Child's Hearing Aid as Experimental or Investigational

Hearing aids for pediatric patients have been the standard of care for childhood hearing loss for decades and are not experimental in any clinical sense. An "experimental or investigational" denial in this context usually means one of three things: (1) Aetna's criteria require a specific style or technology tier and the prescribed device falls outside those parameters; (2) the claim involves a newer hearing-aid technology (such as a specific wireless, Bluetooth, or rechargeable feature set) that Aetna has not updated its policy to address; or (3) the denial is a misclassification and should have been issued on a different ground.

This type of denial is strongly contestable, particularly for a pediatric patient, because the clinical literature and professional guidelines supporting hearing aids in children are extensive and well-established.

## Your Federal Appeal Rights

• ACA §2719 / external review: Non-grandfathered individual and fully-insured group plans entitle your child to independent external review. The window to request external review is typically approximately four months from the final internal denial — verify the exact date on the denial letter.
• ERISA §503 (self-funded plans): Guarantees full-and-fair review and access to Aetna's clinical coverage criteria.
• Expedited review: Critical for children — if the hearing impairment is affecting speech and language development or educational access, request expedited internal and external review simultaneously.

## Documentation to Gather

1. Aetna's clinical policy: Request Aetna's Clinical Policy Bulletin (CPB) that was applied to this denial. You are entitled to this document. Read each criterion and respond to each one in your appeal. 2. FDA clearance documentation for the device: Obtain from the manufacturer confirmation that the device has 510(k) clearance or is otherwise FDA-authorized — this directly contradicts an experimental characterization. 3. Audiologist's clinical justification letter: A letter from the treating audiologist or ENT explaining that the prescribed device is the current standard of care for this child's type and degree of hearing loss, referencing the applicable guideline organization (e.g., the American Academy of Audiology or American Academy of Pediatrics) without asserting specific numbers. 4. Audiogram and diagnosis documentation: Full diagnostic workup confirming the child's hearing loss. 5. Developmental impact statement: A letter from the child's pediatrician, speech-language pathologist, or school audiologist documenting the impact on speech, language, and educational development.

## Criteria-Mapping Structure

| Aetna Experimental Criterion | Your Rebuttal | |---|---| | Device lacks sufficient clinical evidence | FDA clearance letter + audiologist standard-of-care statement | | Technology type is investigational | Manufacturer clearance documentation | | Not covered by applicable guideline body | Reference to relevant professional organization's pediatric hearing aid guidance |

## Next Step

Lead your appeal letter with the FDA-clearance documentation and the audiologist's standard-of-care statement. After internal denial, do not delay requesting external review — independent reviewers routinely overturn experimental/investigational denials for well-established hearing treatments in children.